Amaurosis fugax differential diagnosis

Jump to: navigation, search

Amaurosis fugax Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Amaurosis fugax from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Diagnostic Evaluation

Physical Examination

Laboratory Findings

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Amaurosis fugax differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Amaurosis fugax differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Amaurosis fugax differential diagnosis

CDC on Amaurosis fugax differential diagnosis

Amaurosis fugax differential diagnosis in the news

Blogs on Amaurosis fugax differential diagnosis

Directions to Hospitals Treating Amaurosis fugax

Risk calculators and risk factors for Amaurosis fugax differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Leber's congenital amaurosis is an inherited disease resulting in severe vision loss or blindness that was first described by Theodore Leber in the 19th century. Amaurosis can also occur in ruminants suffering from a vitamin B1 (Thiamin) deficiency due to Thiamine-Related Cerebrocortical Necrosis (CCN).

References


Linked-in.jpg